Veronika Lysenko
Overview
Explore the profile of Veronika Lysenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dietsche L, Stirm K, Lysenko V, Schneidawind C, Tzankov A, Muller A, et al.
Front Oncol
. 2025 Jan;
14:1481713.
PMID: 39834944
Introduction: -rearrangements define a subclass of acute leukemias characterized by a distinct gene expression signature linked to the dysfunctional oncogenic fusion proteins arising from various chromosomal translocations involving the (also...
2.
Losa M, Emmenegger M, De Rossi P, Schurch P, Serdiuk T, Pengo N, et al.
EMBO Mol Med
. 2024 Jul;
16(9):2024-2042.
PMID: 39080493
Extracellularly released molecular inflammasome assemblies -ASC specks- cross-seed Aβ amyloid in Alzheimer's disease. Here we show that ASC governs the extent of inflammation-induced amyloid A (AA) amyloidosis, a systemic disease...
3.
Mueller J, Schimmer R, Koch C, Schneiter F, Fullin J, Lysenko V, et al.
EMBO Mol Med
. 2024 Feb;
16(3):445-474.
PMID: 38355749
TP53-mutant acute myeloid leukemia (AML) and myelodysplastic neoplasms (MDS) are characterized by chemotherapy resistance and represent an unmet clinical need. Chimeric antigen receptor (CAR) T-cells might be a promising therapeutic...
4.
Wildschut M, Mena J, Dordelmann C, van Oostrum M, Hale B, Settelmeier J, et al.
Nat Commun
. 2023 Oct;
14(1):6414.
PMID: 37828014
Myelofibrosis is a hematopoietic stem cell disorder belonging to the myeloproliferative neoplasms. Myelofibrosis patients frequently carry driver mutations in either JAK2 or Calreticulin (CALR) and have limited therapeutic options. Here,...
5.
Grockowiak E, Korn C, Rak J, Lysenko V, Hallou A, Panvini F, et al.
Nat Cancer
. 2023 Aug;
4(8):1193-1209.
PMID: 37550517
Aging facilitates the expansion of hematopoietic stem cells (HSCs) carrying clonal hematopoiesis-related somatic mutations and the development of myeloid malignancies, such as myeloproliferative neoplasms (MPNs). While cooperating mutations can cause...
6.
Lysenko V, Schurch P, Tuzlak S, van Wijk N, Kovtonyuk L, Becher B, et al.
Leukemia
. 2023 Apr;
37(6):1277-1286.
PMID: 37095207
Polycythemia vera (PV) is a hematopoietic stem cell neoplasm driven by somatic mutations in JAK2, leading to increased red blood cell (RBC) production uncoupled from mechanisms that regulate physiological erythropoiesis....
7.
Schurch P, Malinovska L, Hleihil M, Losa M, Hofstetter M, Wildschut M, et al.
Cell Rep
. 2022 Nov;
41(8):111689.
PMID: 36417879
Calreticulin (CALR) is an endoplasmic reticulum (ER)-retained chaperone that assists glycoproteins in obtaining their structure. CALR mutations occur in patients with myeloproliferative neoplasms (MPNs), and the ER retention of CALR...
8.
Kara E, Crimi A, Wiedmer A, Emmenegger M, Manzoni C, Bandres-Ciga S, et al.
Cell Rep
. 2021 Jun;
35(10):109189.
PMID: 34107263
Neuropathological and experimental evidence suggests that the cell-to-cell transfer of α-synuclein has an important role in the pathogenesis of Parkinson's disease (PD). However, the mechanism underlying this phenomenon is not...
9.
Halloy F, Iyer P, Ghidini A, Lysenko V, Barman-Aksozen J, Grubenmann C, et al.
Cell Chem Biol
. 2021 Mar;
28(8):1221-1234.e6.
PMID: 33756123
Erythropoietic protoporphyria (EPP) is a rare disease in which patients experience severe light sensitivity. It is caused by a deficiency of ferrochelatase (FECH), the last enzyme in heme biosynthesis (HBS)....
10.
Rutsche C, Haralambieva E, Lysenko V, Balabanov S, Theocharides A
Blood Adv
. 2021 Feb;
5(3):791-795.
PMID: 33560389
No abstract available.